EffPha Meets You at BIO Asia-Taiwan Exhibition 2026
Exhibitor: EFFICIENT PHARMA MANAGEMENT CORP.
Date: 2026-06-30
Booth No.: M1117
EffPha is a full-service CRO supporting innovative drug development from early-stage strategy to clinical trial execution. Our services include scientific and regulatory consulting, non-clinical study management, regulatory dossier preparation and submission, biostatistics, data management, and clinical study management and monitoring.
Visit us at Booth M1117 to meet our Scientific Directors and cross-functional experts, who bring extensive experience in global drug development, regulatory strategy, and clinical research. Whether you are planning a Pre-IND meeting, preparing an IND submission, designing a clinical study, or advancing your clinical development program, we welcome the opportunity to discuss your development challenges and explore practical solutions.
Visit our booth to discuss your drug development challenges and explore how EffPha can support your development journey.
Also, you can learn more details of EffPha’s services on our website at https://www.effpha.com/ as well as via our company video by cliking the link < https://www.youtube.com/watch?v=SZxxmSuppeA >
EffPha booth number is M1117 in the CRO zone on the 4th floor, at the Nangang Exhibition Center Hall 1 (4F, No.1, Jingmao 2nd Rd., Nangang District, Taipei City, Taiwan). Upon entering through the entrance of the M zone, please walk straight ahead.
Date|Thursday, July 16th – Sunday, July 19th, 2026
Time|10:00 AM ~ 6:00 PM (The exhibition will end at 5:00 PM on the last day.)
More Exhibitor's Press Release
- Wallonia exhibits at BIO Asia-Taiwan 2026 for the 3rd consecutive year: showcasing biotech strengths WALLONIA EXPORT-INVESTMENT AGENCY,BELGIUM / 2026-07-21
- MarkerX Unveils AI-Driven Next-Gen Mass Spec Proteomics Platform in Strategic Alliance with Nanomics MARKER X CO., LTD. / 2026-07-15
- Dasher Neuroscience Signs MOU with Norwegian Research Center to Join the Platform Trial HYDRA DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- Dasher-KY Progresses Phase II AI Drug for MSA, Initiating International Licensing Steps DASHER NEUROSCIENCE HOLDINGS INC. / 2026-07-15
- TaiMed Launches "Rooting for Love" Charity Campaign in Support of Taiwan Lourdes Association TAIMED BIOLOGICS INC. / 2026-07-15
- Exhibition Preview | Youlin Pharma sincerely invites you to attend BIO Asia-Taiwan 2026 SHANGHAI UNIONCLIN CO,. LTD.(UNIONCLIN) / 2026-07-14
- MicroDoctor Cosmetics Showcases Advanced Dissolving Microneedle Technology at BIO Asia MICRODOCTOR BIOMEDICAL CORPORATION / 2026-07-14
- Wireless × Complete Recording × Traceability BrainChild DRS Powers Smarter Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- BrainChild PRV2.0 Precision Measurement Built for Accuracy, Reliability and Better Decisions BRAINCHILD ELECTRONIC CO., LTD. / 2026-07-14
- TaiMed unveil NextGen TMB-365 CD4-Targeted ADC Platform for HIV Functional Cure at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 -EXOLAB ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - MENARINI ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Italian Trade Agency (ITA) in BIO ASIA 2026 - DEAKOS ITALIAN ECONOMIC, TRADE AND CULTURAL PROMOTION OFFICE IN TAIPEI TRADE SECTION / 2026-07-13
- Taiwan Bio partners with Terumo Blood and Cell Technologies to advance automated Treg manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo BCT and Steminent Collaborate to Advance MSC Late-Stage Clinical Manufacturing TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- Terumo Blood and Cell Technologies Introduces APAC CGT Ecosystem Blueprint TERUMO BCT ASIA PTE. LTD. / 2026-07-13
- [Exhibition News] UVAT to Showcase Breakthrough Technologies at BIO Asia-Taiwan 2026! UVAT TECHNOLOGY CO., LTD. / 2026-07-09
- Painless Decoding, Seamless Tracking: Letting Singular Wings Medical's AI Navigate Your Metabolism. SINGULAR WINGS MEDICAL / 2026-07-08
- TaiMed showcase CD4-Targeted platform breakthroughs and High-Quality CDMO Solutions at 2026 BIO Asia TAIMED BIOLOGICS INC. / 2026-07-08
- Lonza Advances Integrated DNA to IND Programs Through Acceleration, De-Risking, and Innovation LONZA / 2026-07-08